Dashboard
1
Poor Management Efficiency with a low ROE of 9.93%
- The company has been able to generate a Return on Equity (avg) of 9.93% signifying low profitability per unit of shareholders funds
2
Company has a low Debt to Equity ratio (avg) at times
3
Poor long term growth as Operating profit has grown by an annual rate 6.30% of over the last 5 years
4
The company has declared Positive results for the last 4 consecutive quarters
5
With ROE of 13.08%, it has a Expensive valuation with a 2.26 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.36%
0%
0.36%
6 Months
-4.17%
0%
-4.17%
1 Year
-8.61%
0%
-8.61%
2 Years
26.61%
0%
26.61%
3 Years
23.21%
0%
23.21%
4 Years
11.29%
0%
11.29%
5 Years
-24.59%
0%
-24.59%
IVF HARTMANN Holding AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.37%
EBIT Growth (5y)
6.30%
EBIT to Interest (avg)
16.80
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
1.07
Tax Ratio
15.78%
Dividend Payout Ratio
37.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.75%
ROE (avg)
9.93%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.26
EV to EBIT
10.77
EV to EBITDA
8.72
EV to Capital Employed
4.36
EV to Sales
1.49
PEG Ratio
2.21
Dividend Yield
4.53%
ROCE (Latest)
40.51%
ROE (Latest)
13.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
148.00
150.60
-1.73%
Operating Profit (PBDIT) excl Other Income
17.60
16.10
9.32%
Interest
0.00
0.30
-100.00%
Exceptional Items
-0.10
-0.10
Consolidate Net Profit
15.10
11.20
34.82%
Operating Profit Margin (Excl OI)
82.10%
66.60%
1.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -1.73% vs 4.51% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 34.82% vs 80.65% in Dec 2022
About IVF HARTMANN Holding AG 
IVF HARTMANN Holding AG
Pharmaceuticals & Biotechnology
IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.






